Shivajyoti Bhattacharjee
Libtayo plus chemotherapy demonstrates five-year survival benefit in advanced NSCLC
By Shivajyoti Bhattacharjee - September 16, 2025
Late-breaking data presented at WCLC highlight significant and sustained improvements in overall survival, including more than doubling five-year survival rates compared to chemotherapy alone
Transforming Healthcare Through AI
By Shivajyoti Bhattacharjee - October 29, 2021
